C-MER Medical repurchases 36,000 shares, lifts treasury stock to 21.13 million

Bulletin Express07-07

C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99 per share, for a total consideration of HKD 35,380.

Following the repurchase, the company’s issued share capital (excluding treasury shares) stands at 1.211 billion, down by 0.003%. Treasury shares increased to 21.13 million, leaving total issued shares unchanged at 1.232 billion.

The purchases were made under the general mandate approved on 20 May 2026, which authorises the company to buy back up to 123.23 million shares. To date, 36,000 shares—equivalent to 0.0029% of the share count on the mandate date—have been repurchased under this authority. A 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 August 2026, in accordance with Hong Kong Stock Exchange rules.

The company confirmed that the repurchase complied with Main Board Rules and that no shares repurchased on 6 July 2026 are designated for cancellation at this time; all remain as treasury shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182456936?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 09:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182456936","market":"us","top_or_hot":-1,"title":"C-MER Medical repurchases 36,000 shares, lifts treasury stock to 21.13 million","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99 per share, for a total consideration of HKD 35,380.</p>\n<p>Following the repurchase, the company’s issued share capital (excluding treasury shares) stands at 1.211 billion, down by 0.003%. Treasury shares increased to 21.13 million, leaving total issued shares unchanged at 1.232 billion.</p>\n<p>The purchases were made under the general mandate approved on 20 May 2026, which authorises the company to buy back up to 123.23 million shares. To date, 36,000 shares—equivalent to 0.0029% of the share count on the mandate date—have been repurchased under this authority. A 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 August 2026, in accordance with Hong Kong Stock Exchange rules.</p>\n<p>The company confirmed that the repurchase complied with Main Board Rules and that no shares repurchased on 6 July 2026 are designated for cancellation at this time; all remain as treasury shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical repurchases 36,000 shares, lifts treasury stock to 21.13 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical repurchases 36,000 shares, lifts treasury stock to 21.13 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-07 09:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99 per share, for a total consideration of HKD 35,380.</p>\n<p>Following the repurchase, the company’s issued share capital (excluding treasury shares) stands at 1.211 billion, down by 0.003%. Treasury shares increased to 21.13 million, leaving total issued shares unchanged at 1.232 billion.</p>\n<p>The purchases were made under the general mandate approved on 20 May 2026, which authorises the company to buy back up to 123.23 million shares. To date, 36,000 shares—equivalent to 0.0029% of the share count on the mandate date—have been repurchased under this authority. A 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 August 2026, in accordance with Hong Kong Stock Exchange rules.</p>\n<p>The company confirmed that the repurchase complied with Main Board Rules and that no shares repurchased on 6 July 2026 are designated for cancellation at this time; all remain as treasury shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1182456936","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182456936","pubTimestamp":1783387437,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER Medical回购3.6万股，库存股增至2113万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99 per share, for a total consideration of HKD 35,380.\nFollowing the repurchase, the company’s issued share capital (excluding treasury shares) stands at 1.211 billion, down by 0.003%. Treasury shares increased to 21.13 million, leaving total issued shares unchanged at 1.232 billion.\nThe purchases were made under the general mandate approved on 20 May 2026, which authorises the company to buy back up to 123.23 million shares. To date, 36,000 shares—equivalent to 0.0029% of the share count on the mandate date—have been repurchased under this authority. A 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 August 2026, in accordance with Hong Kong Stock Exchange rules.\nThe company confirmed that the repurchase complied with Main Board Rules and that no shares repurchased on 6 July 2026 are designated for cancellation at this time; all remain as treasury shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182456936","isCrawlerRequest":true}